Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.73 |
| ▸ | RARB | P10826 | 5/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | PLA2G4B | P0C869 | 7/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8436025 | 0.92 | MAPK1 (0.67) | MAPK1RARBTSHRTP53PLA2G4B | |
| SCHEMBL8074101 | 0.92 | MAPK1 (0.67) | MAPK1RARBTSHRTP53PLA2G4B | |
| Hydrochloric Acid SCHEMBL9812242 | 0.91 | MAPK1 (0.65) | MAPK1RARBTSHRTP53PLA2G4B | |
| Hydrochloric Acid SCHEMBL9812237 | 0.91 | MAPK1 (0.65) | MAPK1RARBTSHRTP53PLA2G4B | |
| SCHEMBL9711933 | 0.89 | TP53 (0.68) | MAPK1RARBTSHRTP53PLA2G4B | |
| SCHEMBL9515560 | 0.89 | TP53 (0.68) | MAPK1RARBTSHRTP53PLA2G4B | |
| SCHEMBL8081094 | 0.87 | MAPK1 (0.73) | MAPK1RARBTSHRTP53PLA2G4B | |
| SCHEMBL8080211 | 0.87 | MAPK1 (0.73) | MAPK1RARBTSHRTP53PLA2G4B | |
| SCHEMBL8432107 | 0.87 | MAPK1 (0.73) | MAPK1RARBTSHRTP53PLA2G4B | |
| SCHEMBL10780882 | 0.85 | MAPK1 (0.71) | MAPK1RARBTSHRTP53PLA2G4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2525834-B1 | GROWTH HORMONES WITH PROLONGED IN-VIVO EFFICACY | NOVO NORDISK HEALTHCARE AG (CH) | 2019-07-17 | — | — | EP | disclosed |